Showing results (1-10 of 1,272) with videos related to

Sort By:
Pageof 128
Plos One|December 6, 2024
Enhancing urban traffic management through shared autonomous electric vehicles and dynamic simulationJingfa Ma, Hu Liu, Lingxiao Chen
The Journal of Invasive Cardiology|July 25, 2024
Kissing-catheter technique in percutaneous transcatheter closure of patent ductus arteriosus: a snare-free approachChen Zhang, Lingxiao Chen, Hong Gu
Scientific Reports|September 2, 2016
The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysisLingxiao Chen, Yujie Chen, Bo Li
Thoracic Cancer|March 7, 2017
Comparing the adverse effects of platinum in combination with etoposide or irinotecan in previously untreated small-cell lung cancer patients with extensive disease: A network meta-analysesYujie Chen, Lingxiao Chen, Diansheng Zhong
Medicine|February 1, 2020
Smoking and alcohol drinking and risk of non-union or delayed union after fractures: A protocol for systematic review and dose-response meta-analysisBin Xu, Lingxiao Chen, Jae Hyup Lee
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 21, 2025
TNF-α drives bladder cancer metastasis via METTL3-mediated m6A modification to promote CLASP2/IQGAP1-dependent cytoskeleton remodelingLingxiao Chen, Cheng He, Zhenyu Ou, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 15, 2021
Comparison of Azacitidine and Decitabine in Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Network Meta-analysisWeiyang Liu, Zhirui Zhou, Lingxiao Chen, et al.
The Pharmacogenomics Journal|May 17, 2025
KHSRP promotes the malignant behavior and cisplatin resistance of bladder cancer cells through the CLASP2/MAPRE1 axisRuizhe Wang, Cheng Zhao, Zhenyu Ou, et al.
BMC Urology|July 4, 2023
High monoamine oxidase a expression predicts poor prognosis for prostate cancer patientsLingxiao Chen, Wei Xiong, Lin Qi, et al.
Translational Lung Cancer Research|July 23, 2021
Differences in treatment effect size between progression-free survival and overall survival in anti-PD-1/PD-L1 inhibitors-based trials in advanced NSCLC: a systematic review and meta-analysisZhirui Zhou, Shengxiang Ren, Lingxiao Chen, et al.
Pageof 128